Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Free Cash Flow: 2018-2025

Historic Free Cash Flow for Verastem (VSTM) over the last 7 years, with Sep 2025 value amounting to -$36.2 million.

  • Verastem's Free Cash Flow fell 52.20% to -$36.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$132.7 million, marking a year-over-year decrease of 32.67%. This contributed to the annual value of -$104.8 million for FY2024, which is 21.20% down from last year.
  • Per Verastem's latest filing, its Free Cash Flow stood at -$36.2 million for Q3 2025, which was down 10.88% from -$32.7 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Free Cash Flow ranged from a high of -$9.9 million in Q4 2021 and a low of -$38.7 million during Q1 2025.
  • For the 3-year period, Verastem's Free Cash Flow averaged around -$29.1 million, with its median value being -$28.0 million (2024).
  • Over the last 5 years, Verastem's Free Cash Flow had its largest YoY gain of 54.23% in 2021, and its largest YoY loss of 124.30% in 2021.
  • Quarterly analysis of 5 years shows Verastem's Free Cash Flow stood at -$9.9 million in 2021, then tumbled by 67.28% to -$16.6 million in 2022, then fell by 5.21% to -$20.3 million in 2023, then crashed by 39.64% to -$25.1 million in 2024, then tumbled by 52.20% to -$36.2 million in 2025.
  • Its Free Cash Flow was -$36.2 million in Q3 2025, compared to -$32.7 million in Q2 2025 and -$38.7 million in Q1 2025.